Ovoca Bio plc reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was EUR 4.7 million compared to EUR 5.61 million a year ago. Basic loss per share from continuing operations was EUR 0.0626 compared to EUR 0.0688 a year ago.

Diluted loss per share from continuing operations was EUR 0.0626 compared to EUR 0.0688 a year ago. Basic loss per share was EUR 0.0576 compared to EUR 0.0688 a year ago. Diluted loss per share was EUR 0.0576 compared to EUR 0.0688 a year ago.